No abstract available
Keywords:
minimal residual disease; treatment monitoring; tumor DNA.
MeSH terms
-
Antineoplastic Agents / pharmacology
-
Antineoplastic Agents / therapeutic use
-
Biomarkers, Tumor / blood*
-
Circulating Tumor DNA / blood*
-
Humans
-
Neoplasms / blood
-
Neoplasms / drug therapy
Substances
-
Antineoplastic Agents
-
Biomarkers, Tumor
-
Circulating Tumor DNA